Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

Steven Darryll Heys, A. W. Hutcheon, T. K. Sarkar, Keith Nicholas Ogston, Iain D Miller, S. Payne, I. Smith, L. G. Walker, O. Eremin

Research output: Contribution to journalArticle

148 Citations (Scopus)
Original languageEnglish
Pages (from-to)S69-74
JournalClinical Breast Cancer
Volume3
Issue numberSuppl 2
Publication statusPublished - 2002

Cite this

Heys, S. D., Hutcheon, A. W., Sarkar, T. K., Ogston, K. N., Miller, I. D., Payne, S., Smith, I., Walker, L. G., & Eremin, O. (2002). Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial. Clinical Breast Cancer, 3(Suppl 2), S69-74.